Patent · US Active

Method of diagnosing and treating asphyxia

US11313866B2 · kind B2 · utility

0Cited by

1References

28Claims

0Family size

Assignee

InfanDx AG · DE

Inventors

Matthias Keller · Maineville, US
Hans-Peter Deigner · Lampertheim, DE
David Enot · Creully, FR
Matthias Kohl · Rottweil, DE
Ronnaug Solberg · Oslo, NO
Olga Saugstad · Oslo, NO
Therese Koal · Innsbruck, AT

Key dates

Filing date	Sep 11, 2017
Grant date	Apr 26, 2022
Priority date	—
Expiry date	May 19, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A90/10
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

A method for in vitro diagnosing asphyxia and disorders related thereto, a method of in vitro estimating duration of hypoxia in a patient subjected to asphyxia, and a method for in vitro monitoring of normoxic, hypoxic and hyperoxic conditions and/or normobaric and hyperbaric oxygen therapy, includes quantitatively detecting in a biological sample of a patient a plurality of asphyxia specific endogenous compounds which are selected from the group consisting of biogenic amines; carnitine-derived compounds; amino acids; bile acids; carboxylic acids; eicosanoids; lipids; precursors of cholesterol, cholesterol metabolites; prostanoids; and sugars.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.